Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2010
03/31/2010CN101687911A Cysteic acid derivatives of anti-viral peptides
03/31/2010CN101687908A Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
03/31/2010CN101687907A Transferases, epimerases, polynucleotides encoding these and uses thereof
03/31/2010CN101687906A Novel methods for recovery of leaf proteins
03/31/2010CN101687030A Improved methods for producing yeast-based vaccines
03/31/2010CN101687027A immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
03/31/2010CN101687025A Haemophilus influenzae type B
03/31/2010CN101687022A prame derived peptides and immunogenic compositions comprising these
03/31/2010CN101687008A Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
03/31/2010CN101686641A Putative cytokinin receptor and methods for use thereof
03/31/2010CN101684473A Method for preparing recombinant cell split essence rPFGF
03/31/2010CN101684155A Nucleotide and protein sequences of nogo genes and methods based thereon
03/31/2010CN101684153A MAWBP antigen polypeptide, use of antoantibody in preparation of tumor detecting agent and detecting agent containing polypeptide
03/31/2010CN101684152A MFAP3L antigen polypeptide, use of antoantibody in preparation of tumor detecting agent and detecting agent containing polypeptide
03/31/2010CN101684151A Protein matter with coagulation activity
03/31/2010CN101684150A DREB transcription factor for regulating peanut stress tolerance and application thereof
03/31/2010CN101684149A Guinea grass drought-induced transcription factor and coding gene and application thereof
03/31/2010CN101684148A Novel surface protein of neisseria meningitidis
03/31/2010CN101684147A moraxella catarrhalis proteins
03/31/2010CN101684146A Novel hcv non-structural polypeptide
03/31/2010CN101684144A Method for preparing ice structure protein
03/31/2010CN101684143A Preparation method of anti-new castle disease virus specific transfer factor and antimicrobial peptide
03/31/2010CN101684142A Preparation method of anti-avian influenza virus specific transfer factor and antimicrobial peptide
03/31/2010CN101684141A Preparation method of specific transfer factor for resisting chicken bursa virus and antimicrobial peptide
03/31/2010CN101684140A Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide
03/31/2010CN101683533A Gene transfer-mediated angiogenesis therapy
03/31/2010CN101683520A Methods for treating tweak-related conditions
03/31/2010CN100596307C Chicken silk feather character gene and uses thereof
03/30/2010US7687614 Monomeric and dimeric fluorescent protein variants and methods for making same
03/30/2010US7687611 Assay for the separation and quantification of hemagglutinin antigens
03/30/2010US7687610 having an increased activity over the wild-type human glycoprotein; reproduction disorders; cancer such as thyroid carcinoma
03/30/2010US7687609 Galectin-glycosaminoglycan complex and method for controlling galectin activity
03/30/2010US7687607 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS)
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/30/2010US7687464 fusion proteins; membrane proteins; cancer, metastasis
03/30/2010US7687463 Treatment of amyotrophic lateral sclerosis
03/30/2010US7687461 including PEGylated TNF (tumor necrosis factor) variants; use treating disorders such as diabetes, rheumatoid arthritis and lupus
03/30/2010US7687460 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents
03/30/2010US7687457 Cyclic molecular framework and derivatives thereof
03/30/2010US7687455 comprising fluorocarbon vector-antigen, immunogens; vaccines, immunotherapy
03/30/2010US7687454 Effectors of innate immunity determination
03/30/2010US7687266 Pluripotency determining factors and uses thereof
03/30/2010US7687240 Process for increasing RSV surface glycoprotein yields using a mutant strain of RSV
03/30/2010CA2484177C Biodegradable, anionic polymers derived from the amino acid l-tyrosine
03/30/2010CA2428642C Methods for large scale production of recombinant dna-derived tpa or k2s molecules
03/30/2010CA2409347C Enhanced protein thermostability and temperature resistance
03/30/2010CA2356404C Method for accelerating the rate of mucociliary clearance
03/30/2010CA2292792C Recombinant adenoviral vectors comprising a splicing sequence
03/30/2010CA2285687C An oleosin 5' regulatory region for the modification of plant seed lipid composition
03/30/2010CA2241604C Mesothelium antigen and methods and kits for targeting it
03/30/2010CA2174652C Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis
03/30/2010CA2171207C Methods for regulating gastrointestinal motility
03/30/2010CA2162150C Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/30/2010CA2144223C Effector proteins of rapamycin
03/29/2010CA2639878A1 Synthetic antigen mimetics immuno-reactive with rheumatoid arthritis auto-antibodies
03/25/2010WO2010034034A1 Peptidomimetic macrocycles
03/25/2010WO2010034032A2 Methods for preparing purified polypeptide compositions
03/25/2010WO2010034031A1 Peptidomimetic macrocycles
03/25/2010WO2010034029A1 Peptidomimetic macrocycles
03/25/2010WO2010034028A1 Peptidomimetic marcrocycles
03/25/2010WO2010034018A2 Msp nanopores and related methods
03/25/2010WO2010033868A2 Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof
03/25/2010WO2010033854A2 Avian derived fusion proteins
03/25/2010WO2010033688A2 Nucleic acids encoding spider glue proteins and methods of use thereof
03/25/2010WO2010033667A2 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
03/25/2010WO2010033337A1 Rabies virus-based recombinant immunocontraceptive compositions and methods of use
03/25/2010WO2010033321A2 Novel bacillus thuringiensis gene with lepidopteran activity
03/25/2010WO2010033319A2 Novel bacillus thuringiensis gene with lepidopteran activity
03/25/2010WO2010033294A1 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
03/25/2010WO2010033240A2 Carbohydrate-based drug delivery polymers and conjugates thereof
03/25/2010WO2010033224A1 Polymer conjugates of kiss1 peptides
03/25/2010WO2010033222A2 Polymer conjugates of ziconotide peptides
03/25/2010WO2010033220A2 Modified therapeutics peptides, methods of their preparation and use
03/25/2010WO2010033218A1 Polymer conjugates of osteocalcin peptides
03/25/2010WO2010033217A1 Polymer conjugates of cd-np peptides
03/25/2010WO2010033215A2 Polymer conjugates of aod-like peptides
03/25/2010WO2010033205A1 Polymer conjugates of v681-like peptides
03/25/2010WO2010033204A2 Polymer conjugates of c-peptides
03/25/2010WO2010033138A1 Growth factor supplement for stem cell cultures
03/25/2010WO2010033085A1 Chinese hamster ovary cell lines
03/25/2010WO2010033031A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/25/2010WO2010032833A1 Molecular probe precursor for imaging of pancreatic islet, and use thereof
03/25/2010WO2010032786A1 Transgenic animal
03/25/2010WO2010032696A1 Diagnosis method and therapeutic method for cancer
03/25/2010WO2010032458A1 Novel biomarker for non-alcoholic fatty liver disease, and method for detecting non-alcoholic fatty liver disease by using the biomarker
03/25/2010WO2010032228A1 Allergoids derived from allergenes
03/25/2010WO2010032008A2 Dendritic cell modulatory molecule
03/25/2010WO2010032001A1 Sensor
03/25/2010WO2010031783A1 Mutant pestivirus with mutations in core gene and ns3 region
03/25/2010WO2010031707A1 Neuropeptide-2 receptor (y-2r) agonists and uses thereof
03/25/2010WO2010031312A1 Regulation of nitrogen starvation response
03/25/2010WO2010031171A1 Iap bir domain binding compounds
03/25/2010WO2010031168A1 HETERO-MULTIVALENT BINDING AGENTS FOR MEMBERS OF THE TGFβ SUPERFAMILY
03/25/2010WO2010031114A1 Novel receptor hetero-dimers/-oligomers
03/25/2010WO2010031113A1 Viral polypeptides and methods
03/25/2010WO2010016760A3 Immunogenic composition for the treatment of e. faecium infection
03/25/2010WO2010013071A3 Methods concerning ppar delta and antagonists thereof
03/25/2010WO2010006239A3 Regulation of apoptosis by neural specific splice variants of ig20
03/25/2010WO2009156405A8 Novel immunoadjuvant flagellin-based compounds and use thereof
1 ... 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 ... 2916